CD14 and complement crosstalk and largely mediate the transcriptional response to Escherichia coli in human whole blood as revealed by DNA microarray

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Lau, Corinna ^a   Nygård, Ståle ^b,c   Fure, Hilde ^a   Olstad, Ole Kristoffer ^d   Holden, Marit ^e   Lappegård, Knut Tore ^a,f   Brekke, Ole Lars ^a,f   Espevik, Terje ^g   Hovig, Eivind ^b,c   Mollnes, Tom Eirik ^a,f,g,h  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d OUS   (Norway)

^e NORWEGIAN COMPUTING CENTER   (Norway)

^f UNIVERSITY OF TROMSØ   (Norway)

^g NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; PATTERN RECOGNITION RECEPTOR; COMPLEMENT;

ARTICLE; BLOOD; CONTROLLED STUDY; DNA MICROARRAY; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; INNATE IMMUNITY; NONHUMAN; REVERTANT; GENETICS; METABOLISM;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

ANTIGENS, CD14; COMPLEMENT SYSTEM PROTEINS; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION, GENETIC;

EID: 84923792613     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117261     Document Type: Article

References (42)

1. Hobson MJ, Wong HR (2011) Finding new therapies for sepsis: the need for patient stratification and the use of genetic biomarkers. Crit Care 15: 1009. cc10527 [pii];. doi: 10.1186/cc10527 PMID: 22169064
2. Rivers EP, Jaehne AK, Nguyen HB, Papamatheakis DG, Singer D, et al. (2013) Early biomarker activity in severe sepsis and septic shock and a contemporary review of immunotherapy trials: not a time to give up, but to give it earlier. Shock 39: 127-137. 10.1097/SHK.0b013e31827dafa7 [doi];00024382-201302000-00003 [pii]. PMID: 23324881
3. Barratt-Due A, Pischke SE, Brekke OL, Thorgersen EB, Nielsen EW, et al. (2012) Bride and groom in systemic inflammation-the bells ring for complement and Toll in cooperation. Immunobiology 217: 1047-1056. S0171-2985(12)00183-0 [pii];. doi: 10.1016/j.imbio.2012.07.019 PMID: 22964230
4. Mollnes TE, Christiansen D, Brekke OL, Espevik T (2008) Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response. Adv Exp Med Biol 632: 253-263. PMID: 19025127
5. Castellheim A, Brekke OL, Espevik T, Harboe M, Mollnes TE (2009) Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand J Immunol 69: 479-491. SJI2255 [pii];. doi: 10.1111/j.1365-3083.2009.02255.x PMID: 19439008
6. Mollnes TE, Brekke OL, Fung M, Fure H, Christiansen D, et al. (2002) Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100: 1869-1877. PMID: 12176911
7. Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, et al. (2006) Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 12: 682-687. nm1419 [pii];10.1038/nm1419 [doi]. PMID: 16715088
8. Pugin J, Heumann ID, Tomasz A, Kravchenko VV, Akamatsu Y, et al. (1994) CD14 is a pattern recognition receptor. Immunity 1: 509-516. 1074-7613(94)90093-0 [pii]. PMID: 7534618
9. Weber C, Muller C, Podszuweit A, Montino C, Vollmer J, et al. (2012) Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects). Immunology 136: 64-77. doi: 10.1111/j.1365-2567.2012.03559.x PMID: 22260507
10. Ostuni R, Zanoni I, Granucci F (2010) Deciphering the complexity of Toll-like receptor signaling. Cell Mol Life Sci 67: 4109-4134. doi: 10.1007/s00018-010-0464-x PMID: 20680392
11. Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20: 197-216. 10.1146/annurev.immunol.20.083001.084359 [doi];083001.084359 [pii]. PMID: 11861602
12. Fan H, Li P, Zingarelli B, Borg K, Halushka PV, Birnbaumer L, et al. (2011) Heterotrimeric Galpha(i) proteins are regulated by lipopolysaccharide and are anti-inflammatory in endotoxemia and polymicrobial sepsis. Biochim Biophys Acta 1813: 466-472. S0167-4889(11)00020-6 [pii];. doi: 10.1016/j.bbamcr.2011.01.012 PMID: 21255617
13. Klos A, Tenner AJ, Johswich KO, Ager RR, Reis ES, et al. (2009) The role of the anaphylatoxins in health and disease. Mol Immunol 46: 2753-2766. S0161-5890(09)00196-5 [pii]; doi: 10.1016/j.molimm.2009.04.027 PMID: 19477527
14. Wang Y, Tang Y, Teng L, Wu Y, Zhao X, et al. (2006) Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 7: 139-147. ni1294 [pii];10.1038/ni1294 [doi]. PMID: 16378096
15. Hajishengallis G, Lambris JD (2010) Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol 31: 154-163. S1471-4906(10)00003-7 [pii];. doi: 10.1016/j.it.2010.01.002 PMID: 20153254
16. Lappegard KT, Christiansen D, Pharo A, Thorgersen EB, Hellerud BC, et al. (2009) Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature. Proc Natl Acad Sci U S A 106: 15861-15866. 0903613106 [pii];. doi: 10.1073/pnas.0903613106 PMID: 19717455
17. O 'Neill LA, Sheedy FJ, McCoy CE (2011) MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 11: 163-175. nri2957 [pii];. doi: 10.1038/nri2957 PMID: 21331081
18. Wurfel MM, Park WY, Radella F, Ruzinski J, Sandstrom A, et al. (2005) Identification of high and low responders to lipopolysaccharide in normal subjects: an unbiased approach to identify modulators of innate immunity. J Immunol 175: 2570-2578. 175/4/2570 [pii]. PMID: 16081831
19. Wang M, Krauss JL, Domon H, Hosur KB, Liang S, et al. (2010) Microbial hijacking of complement-toll-like receptor crosstalk. Sci Signal 3: ra11. 3/109/ra11 [pii];. doi: 10.1126/scisignal.2000697 PMID: 20159852
20. Seow V, Lim J, Iyer A, Suen JY, Ariffin JK, et al. (2013) Inflammatory responses induced by lipopolysaccharide are amplified in primary human monocytes but suppressed in macrophages by complement protein C5a. J Immunol 191: 4308-4316. jimmunol.1301355 [pii];. doi: 10.4049/jimmunol.1301355 PMID: 24043889
21. Taxman DJ, Holley-Guthrie EA, Huang MT, Moore CB, Bergstralh DT, et al. (2011) The NLR adaptor ASC/PYCARD regulates DUSP10, mitogen-activated protein kinase (MAPK), and chemokine induction independent of the inflammasome. J Biol Chem 286: 19605-19616. M111.221077 [pii];. doi: 10.1074/jbc.M111.221077 PMID: 21487011
22. Oikonomopoulou K, Ricklin D, Ward PA, Lambris JD (2012) Interactions between coagulation and complement-their role in inflammation. Semin Immunopathol 34: 151-165. doi: 10.1007/s00281-011-0280-x PMID: 21811895
23. Park JM, Greten FR, Wong A, Westrick RJ, Arthur JS, et al. (2005) Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis-CREB and NF-kappaB as key regulators. Immunity 23: 319-329. S1074-7613(05)00270-0 [pii];10.1016/j.immuni.2005.08.010 [doi]. PMID: 16169504
24. Chuang SY, Yang CH, Chou CC, Chiang YP, Chuang TH, et al. (2013) TLR-induced PAI-2 expression suppresses IL-1beta processing via increasing autophagy and NLRP3 degradation. Proc Natl Acad Sci U S A 110: 16079-16084. 1306556110 [pii];. doi: 10.1073/pnas.1306556110 PMID: 24043792
25. Ma CY, Shi GY, Shi CS, Kao YC, Lin SW, et al. (2012) Monocytic thrombomodulin triggers LPS- and gram-negative bacteria-induced inflammatory response. J Immunol 188: 6328-6337. jimmunol. 1102266 [pii];. doi: 10.4049/jimmunol.1102266 PMID: 22573811
26. Pierrakos C, Vincent JL (2010) Sepsis biomarkers: a review. Crit Care 14: R15. cc8872 [pii];. doi: 10.1186/cc8872 PMID: 20144219
27. Oku R, Oda S, Nakada TA, Sadahiro T, Nakamura M, et al. (2013) Differential pattern of cell-surface and soluble TREM-1 between sepsis and SIRS. Cytokine 61: 112-117. S1043-4666(12)00680-1 [pii];. doi: 10.1016/j.cyto.2012.09.003 PMID: 23046618
28. Wang HJ, Zhang PJ, Chen WJ, Feng D, Jia YH, et al. (2012) Four serum microRNAs identified as diagnostic biomarkers of sepsis. J Trauma Acute Care Surg 73: 850-854. 01586154-201210000-00009 [pii]. doi: 10.1097/TA.0b013e31825a7560 PMID: 23026916
29. Haneklaus M, Gerlic M, O'Neill LA, Masters SL (2013) miR-223: infection, inflammation and cancer. J Intern Med 274: 215-226. doi: 10.1111/joim.12099 PMID: 23772809
30. Liu TF, Brown CM, El GM, McPhail L, Millet P, et al. (2012) Fueling the flame: bioenergy couples metabolism and inflammation. J Leukoc Biol 92: 499-507. jlb.0212078 [pii];. doi: 10.1189/jlb.0212078 PMID: 22571857
31. Hou Y, Moreau F, Chadee K (2012) PPARgamma is an E3 ligase that induces the degradation of NFkappaB/p65. Nat Commun 3: 1300. ncomms2270 [pii];. doi: 10.1038/ncomms2270 PMID: 23250430
32. Yan C, Zhu M, Staiger J, Johnson PF, Gao H (2012) C5a-regulated CCAAT/enhancer-binding proteins beta and delta are essential in Fcgamma receptor-mediated inflammatory cytokine and chemokine production in macrophages. J Biol Chem 287: 3217-3230. M111.280834 [pii];. doi: 10.1074/jbc.M111.280834 PMID: 22147692
33. Katragadda M, Magotti P, Sfyroera G, Lambris JD (2006) Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin. J Med Chem 49: 4616-4622. 10.1021/jm0603419 [doi]. PMID: 16854067
34. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210. PMID: 11752295
35. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. S1046-2023(01)91262-9 [pii]. PMID: 11846609
36. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80. gb-2004-5-10-r80 [pii];10.1186/gb-2004-5-10-r80 [doi]. PMID: 15461798
37. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3. 10.2202/1544-6115.1027 [doi].
38. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B 57: 289-300.
39. Warnes GR (2012) Includes R source code and/or documentation contributed by: Bolker B, Bonebakker L, Gentleman R, Huber W, Laiw A, Lumley T, Maechler M, Magnusson A, Moeller S, Schwartz M, Venables B gplots: Various R programming tools for plotting data. R package version 2 11 0.
40. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: 3.
41. Barrell D, Dimmer E, Huntley RP, Binns D, O'Donovan C, et al. (2009) The GOA database in 2009-an integrated Gene Ontology Annotation resource. Nucleic Acids Res 37: D396-D403. gkn803 [pii];. doi: 10.1093/nar/gkn803 PMID: 18957448
42. Finch AM, Wong AK, Paczkowski NJ, Wadi SK, Craik DJ, et al. (1999) Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. J Med Chem 42: 1965-1974. 10.1021/jm9806594 [doi];jm9806594 [pii]. PMID: 10354404